Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

The hydrogel helps heal diabetic wounds by reducing infection and inflammation.

Itraconazole effectively treats scalp fungus, with continuous use more effective than pulse therapy.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Tumor proteins can both promote and suppress cancer, depending on the situation.

High glycine–tyrosine keratin-associated proteins help make hair strong and maintain its shape.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Gefitinib can cause rare scarring hair loss.

Gefitinib can cause hair and eyebrow darkening.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Clotrimazole, an antifungal cream, may safely reduce skin pigmentation by breaking down the enzyme needed for making melanin.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

The document suggests creating a secure database for indigenous knowledge and recommends that the TKDL actively fight patents that slightly alter traditional knowledge.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.